Clinical Division of Social Psychiatry, Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria.
Clinical Institute of Neurology, Center for Brain Research, Medical University of Vienna, Vienna, Austria.
Alzheimers Dement. 2020 Nov;16(11):1591-1595. doi: 10.1002/alz.12146. Epub 2020 Aug 18.
Alcohol-related dementia (ARD) is a common and severe co-morbidity in alcohol use disorder (AUD). We propose brain iron overload (BIO) to be an important and previously neglected pathogenic process, accelerating cognitive decline in AUD. Furthermore, we suggest thiamine, which is frequently depleted in AUD, to be a key modulator in this process: Thiamine deficiency impairs the integrity of the blood-brain barrier, thereby enabling iron to pass through and accumulate in the brain. This hypothesis is based on findings from animal, translational, and neuroimaging studies, discussed in this article. To validate this hypothesis, translational studies focusing on brain iron homeostasis in AUD, as well as prospective clinical studies investigating prevalence and clinical impact of BIO in AUD, should be conducted. If proven right, this would change the understanding of ARD and may lead to novel therapeutic interventions in prevention and treatment of ARD.
酒精相关痴呆(ARD)是酒精使用障碍(AUD)的一种常见且严重的共病。我们提出脑铁过载(BIO)是一个重要且以前被忽视的致病过程,可加速 AUD 患者的认知能力下降。此外,我们还认为硫胺素(在 AUD 中经常消耗)是这一过程中的关键调节剂:硫胺素缺乏会损害血脑屏障的完整性,从而使铁能够穿过并在大脑中积累。这一假设基于本文讨论的动物、转化和神经影像学研究的结果。为了验证这一假设,应该进行专注于 AUD 中脑铁动态平衡的转化研究,以及前瞻性临床研究,以调查 BIO 在 AUD 中的患病率和临床影响。如果得到证实,这将改变对 ARD 的认识,并可能为 ARD 的预防和治疗带来新的治疗干预措施。